The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | D | Dermatologicals | |
| 2 | D06 | Antibiotics and chemotherapeutics for dermatological use | |
| 3 | D06B | Chemotherapeutics for topical use | |
| 4 | D06BX | Other chemotherapeutics | |
| 5 | D06BX03 |
| Active Ingredient | Description | |
|---|---|---|
| Tirbanibulin |
Tirbanibulin disrupts microtubules by direct binding to tubulin, which induces cell cycle arrest and apoptotic death of proliferating cells, and is associated with disruption of Src tyrosine kinase signalling. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| KLISYRI Ointment | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
